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Health policy evaluations commonly use data before and after a pol-
icy change and assume that, without the intervention, the expected 
outcomes for the treated and control groups would have followed 
parallel trends. This assumption underpins the standard difference-
in-differences (DiD) estimator and implies that any differences 
between the comparator groups due to unobserved confounders 
are time-constant. However, the “parallel trends” assumption is 
often implausible, particularly in a health policy setting. When the 
parallel trends assumption is violated, DiD approaches provide bi-
ased estimates of the effect of the health policy.1,2 DiD has been 
widely applied to policy evaluations within health economics4-10 and 
health services research.11-15 As recently illustrated in re-evaluating 
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0f;1|b;ĹTo compare interactive fixed effects (IFE) and generalized synthetic con-
trol (GSC) methods to methods prevalent in health policy evaluation and re-evaluate 
the impact of the hip fracture best practice tariffs introduced for hospitals in England 
in 2010.
	-|-"ou1;vĹSimulations and Hospital Episode Statistics.
"|7	;vb]mĹBest practice tariffs aimed to incentivize providers to deliver care in 
line with guidelines. Under the scheme, 62 providers received an additional payment 
for each hip fracture admission, while 49 providers did not. We estimate the impact 
using difference-in-differences (DiD), synthetic control (SC), IFE, and GSC methods. 
We contrast the estimation methods' performance in a Monte Carlo simulation study.
ubm1br-Ѵbm7bm]vĹUnlike DiD, SC, and IFE methods, the GSC method provided reli-
able estimates across a range of simulation scenarios and was preferred for this case 
study. The introduction of best practice tariffs led to a 5.9 (confidence interval: 2.0 
to 9.9) percentage point increase in the proportion of patients having surgery within 
ƓѶ_ouv-m7-v|-|bv|b1-ѴѴbmvb]mb=b1-m|ƏĺѵŐ1om=b7;m1;bm|;u-ѴĹƴƐĺƓ|oƏĺƓőr;u1;m|-
age point reduction in 30-day mortality.
om1ѴvbomvĹThe GSC approach is an attractive method for health policy evaluation. 
We cannot be confident that best practice tariffs were effective.
  + )  ! 	 "
difference-in-differences, interactive fixed effects, pay-for-performance, policy evaluation, 
synthetic control
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a pay-for-performance (P4P) scheme,3 a study's policy conclusions 
can rest on the approach taken to causal inference.3
The synthetic control (SC) method16,17 has been viewed as an 
attractive alternative to DiD as it avoids the parallel trends assump-
tion. In essence, the SC method constructs a comparator for the 
intervention group, the synthetic control, as a weighted average of 
the available control units. Each unit is weighted to ensure that the 
mean outcomes of the synthetic control track those of the treated 
unit(s) prior to the intervention.3,17-24 However, despite its wide 
use, critics have shown that the SC approach may provide biased 
estimates in settings when few pre-intervention periods are avail-
able2,25; treatment assignment is correlated with time-varying unob-
served confounders,26 or where the outcomes of the treated units 
cannot be obtained by weighting the control units' outcomes by val-
ues between 0 and 1 (ie, the treated units are not within the “con-
vex hull”), leading to poor overlap. 17,25,27 Statistical inference is also 
somewhat problematic under the SC approach.28 Concerns about 
the DiD and SC approaches have encouraged recent methodological 
advances.29-35 However, these methods have not been considered in 
the health policy evaluation domain, which is characterized by par-
ticular challenges, notably the (im)plausibility of the parallel trends 
assumption, the possibility of heterogeneous treatment effects, and 
that there may be few pretreatment periods. Here, we consider two 
of these approaches: (a) interactive fixed effect (IFE) models, and (b) 
the generalized synthetic control (GSC) method, both are novel to 
this context.
IFE models are flexible regression approaches that allow for 
multiple time-constant unobserved covariates, each of which may 
have effects that vary across time36-39 relaxing the parallel trends as-
sumption.40 IFE models nest the fixed effects models routinely used 
within DiD estimation, but may produce biased estimates when pol-
icy effects are modified by unobserved covariates, that is effects are 
heterogeneous.41 For instance, hospital quality, which is generally 
unobserved, may moderate the effect that a new health policy has 
on outcomes.
The GSC method41 seeks to overcome this limitation by com-
bining insights from the SC literature with the efficiency gains of 
IFE models. The GSC approach allows a separate (counterfactual) 
potential outcome to be estimated for each treated unit, allowing 
heterogeneous treatment effects to be consistently estimated. It 
has been argued that the GSC method maintains the approximately 
unbiasedness property of the SC estimator but offers improved ef-
ficiency. Despite these desirable features, the GSC method has not 
been considered in a published health policy evaluation.-Ք
We contrast the IFE and GSC methods with DiD and SC methods 
in a case study and in Monte Carlo simulations. We revisit an eval-
uation of a pay-for-performance scheme, best practice tariffs (BPT) 
for hip fractures, introduced for hospitals in the English NHS.2,42 The 
incidence of hip fractures in the UK is rising annually and is currently 
estimated at 10.2 per 10 000 per year.43 The cost to the hospital 
services of hip fracture are substantial, and have been estimated to 
be £1,131 million in the year of the fracture.44 Thus the impact of 
policies such as BPT are of interest to policymakers. Our simulation 
study extends the precedent comparison of Xu,41 by considering set-
tings relevant to the HSR context, namely few (<10) pretreatment 
periods, highly imbalanced numbers of treatment vs control units, 
and serial correlation. While all methods were susceptible to shocks 
that impacted treated and control units differently in the post-treat-
ment period, the simulations show that the IFE approach otherwise 
avoids bias when treatment effects are homogenous but provides 
biased estimates under heterogeneity. By contrast, the GSC method 
reports efficient estimates with low bias in the presence of nonpar-
allel trends, heterogeneous effects, and relatively few pretreatment 
periods.
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Hospital pay-for-performance (P4P) schemes link a portion of pro-
vider income to achieving predefined quality targets. These schemes 
intend to encourage providers to engage in “desirable” behaviors. 
However, P4P schemes may shift resources toward rewarded vs un-
rewarded dimensions of care quality, and so have negative spill-over 
effects.45 A number of studies have concluded that hospital pay-for-
performance schemes have not had the desired impact.14,46-51 The 
international evidence on P4P has been criticized for failing to pro-
vide reliable estimates of these schemes' relative effectiveness.52-54
The particular P4P scheme considered here, the BPT for hip frac-
tures, was introduced for participating English NHS hospitals from 
April 2010,2,42 who were paid a fixed sum, set at £445 in the 2010/11 
financial year,55 for each hip fracture admission if certain conditions 
)_-||_bvv|7-77v
 Health policy evaluations with pre-post designs are 
challenging as the parallel trends assumption underly-
ing difference-in-differences estimation often does not 
hold for all outcomes.
 This was the case for the evaluation of the best practice 
tariffs (BPT) for hip fractures, a pay-for-performance 
scheme, introduced for hospitals in the English NHS.
 Alternative estimation methods have yielded contrast-
ing estimates of the impacts of this BPT.
 In our simulations, the generalized synthetic control ap-
proach outperformed more commonly used methods 
(difference-in-differences and synthetic control meth-
ods) and hence was the preferred approach for the case 
study.
 It suggests that the BPT for hip fractures increased the 
proportion of patients who had surgery within 48 hours 
of admission, but did not statistically significantly re-
duce 30-day mortality.
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representing “best practice” were met.0Ք The BPT payments repre-
sented a considerable share of the total payment to providers for 
hip fracture care, 14% in 2011/12,55 so one might anticipate that 
providers would respond to these altered incentives to provide best 
practice care.
A published survey and qualitative interviews suggested that 
BPT participation was influenced by factors unobserved by research-
ers421Ք, such as the resources required for this scheme, the quality 
of facilities available, and the expected benefits from participation. 
These may have had time-varying effects on the outcomes. Hence, a 
priori, it was unclear whether the parallel trends assumption held for 
each outcome. For one outcome, the proportion of patients who had 
surgery within 48 hours, the parallel trends assumption appeared 
plausible (Figure 1), and tests suggested this assumption could not 
be rejected (P = .9255).7Ք However, for the primary outcome, mor-
tality within 30 days, the parallel trends assumption appeared less 
plausible (Figure 2) and the null hypothesis of parallel trends was 
rejected (P = .039).
Previous analyses, using DiD and SC methods, found that con-
clusions regarding the effects of the BPT differed by method.2 
Estimates based on DiD reported that the introduction of BPTs led 
to a statistically significant reduction in mortality, whereas the SC 
method failed to reject the null of no effect across all outcomes and 
indicated a smaller impact on mortality compared to DiD. However, 
the authors raised concerns regarding the efficiency of the SC esti-
mates, motivating this re-analysis using alternative methods.
We re-analyze the data used in a previously published study,2 
consisting of hospital admissions from 62 hospital trusts that re-
ported receiving at least some BPT payments (treated group) and 49 
trusts that reported receiving no payments under the scheme (con-
trol group). Panel data were available for twelve quarters before, and 
four after, the scheme's introduction. All analyses were conducted at 
the level of the hospital-quarter.
The outcomes considered are the proportion of patients receiv-
ing surgery within 48 hours of an emergency admission and the pro-
portion of patients that die within 30 days of admission. We adjust 
for baseline covariates according to age group, gender, and source 
of admission.
ƒՊ |Պ$	"
Suppose there are i = 1,…,n units, and T time periods, where t = 1,…t' 
are pretreatment, and t' + 1,…,T are post-treatment. The potential 
outcomes56 for unit i in period t in the presence and absence of 
treatment are denoted by Y1
it
 and Y0
it
, respectively. Let Dit be an indi-
cator equal to one if unit i is treated (exposed to the policy) in period 
t and zero otherwise. The observed outcome can be written as:
We assume the following factor model for the potential outcome 
in the absence of treatment:
where Xit is a (1 × k) vector of observed time-varying covariates, β is 
the (k × 1) vector of their coefficients, assumed to be the same for both 
groups, µir (r = 1, …, R) represents an unobserved time-invariant vari-
able with λrt capturing the effect of that unobserved variable in pe-
riod t, and 휀it represents exogenous, unobserved idiosyncratic shocks. 
Allowing for an additive treatment effect that may differ by individual 
Yit=DitY
1
it
+ (1−Dit)Y
0
it
Y
0
it
=X
�
it
훽+
(
휆1t휇i1…+휆Rt휇iR
)
+휀it
   & !   Ɛ Պ Proportions of hip fracture patients receiving surgery within 48 h of emergency admission in participating vs nonparticipating 
hospitals [Color figure can be viewed at wileyonlinelibrary.com]
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and period (τit), and letting μb = [μi1,…, μiR] and λt = [λ1t,…, λRt], the ob-
served outcome can be written as:
The estimand of interest is the average treatment effect for the 
treated (ATT) after controlling for covariates, E(τit|Dit = 1, Xit) over the 
post-treatment period, t > tனĺ
ƒĺƐՊ|Պ	b==;u;m1;bm	b==;u;m1;vŐ	b	ő
Note that if 흁i= [1,휇i] and 흀t= [휆t,1], equation 1 would correspond to 
a two-way fixed effects model:
In this case, the parallel trends assumption will hold57,58:
where tன u;ru;v;m|v |_; =bm-Ѵ ru;|u;-|l;m| r;ubo7ķ -m7 |_; 1om7b-
tional ATT can be estimated using DiD with two-way fixed effects 
regression.24,59-61;Ք=Ք
ƒĺƑՊ|Պm|;u-1|b;=b;7;==;1|v
Interactive fixed effects models rely on an alternative set of esti-
mation approaches for the common factor structure 흀t
′흁i.
37 Here, 
we estimate the IFE model using the iterative principal component 
estimator.37 This approach consists of iterating between (a) es-
timating 흀t and 흁i using principal components while holding 휷̂ 
constant, and (b) estimating 휷 by regressing (Y− 흀̂
�
t
흁̂i) on *, until 
convergence is achieved. The number of factors to include can be 
chosen according to cross-validation as described in Algorithm 1 
in Xu.41 It is preferable to include too many rather than too few 
factors.62
One limitation of the IFE approach is that when treatment ef-
fects are moderated by the unobserved factors, the estimated av-
erage treatment effect may be biased, since the heterogeneity in 
treatment effects leads to biased estimates of the common factors 
and hence the implied treatment-free potential outcome.
ƒĺƒՊ|Պ"m|_;|b11om|uoѴŐ"ől;|_o7
The synthetic control method has been shown to provide an approx-
imately unbiased estimator of the ATT for a treated unit17 when out-
comes are determined by a linear factor model with time-invariant 
covariates (Zi), such as:
The SC method aims to estimate the unit level causal effect 
τit for the treated unit, by constructing a “synthetic control,” or a 
weighted average of the control units that has similar outcomes 
and observed covariates to the treated unit over the pre-interven-
tion period:
(1)Yit=X
′
it훽+휆
�
t
흁i+Dit휏it+휀it
(2)Yit=X
′
it훽+휇i+휆t+Dit휏it+휀it
E
(
Y
0
it
−Y
0
it�
|Dit=1,Xit
)
=E
(
Y
0
it
−Y
0
it�
|Dit=0,Xit
)
∀t> t
� (A1: Parallel trends).
(3)Yit=휃tZi+흀t
′흁i+Dit휏it+휀it
∑
j∈Control
wjYjt≈Y1t,∀t≤T0 and
∑
j∈Control
wjZi≈Z1,∀t≤T0
   & !   Ƒ Պ Proportions of hip fracture patients dying within 30 d of emergency admission in participating vs nonparticipating hospitals
Color figure can be viewed at wileyonlinelibrary.com]
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where wj is an element of ) representing the weight for control j, 
with 0≤wj≤1. The synthetic control is formed by finding the vector 
of weights ) that minimizes (X1−X0W)� V (X1−X0W) subject to the 
weights in W being positive and summing to 1, where X1 and X0 con-
tain the pretreatment outcomes and covariates for the treated unit and 
control units, respectively,17 and V captures the relative importance 
of these variables as predictors of the outcome of interest. When X1 
and X0 include all of the pre-intervention outcomes, other covariates 
do not influence the weights and hence can be excluded as is done 
in our analysis below. If the synthetic control and treated unit have 
similar outcomes over an extended pre-intervention period, it is plau-
sible that they have similar observed and unobserved predictors of the 
outcome.25 Hence, the postintervention outcome for the synthetic 
control represents the counterfactual treatment-free potential out-
come for the treated unit (̂Y0
1t
). The SC method assumes conditional 
independence2/ignorability74:
where Y0
ih
 is a vector of potential outcomes in the h time periods prior to 
treatment.
Since the weights are restricted to be between 0 and 1, the 
treated unit must lie within the “convex hull” of the control units 
to avoid bias.17 The treatment effect for the treated unit (i = 1), τ1t, 
can be estimated by (Y�
1t
−
̂Y0
1t
) for each postintervention period sep-
arately, and these can be averaged over time to obtain an ATT over 
the postintervention period.
The SC approach can be applied to multiple treated units by ap-
plying the method to each treated unit or, as we do here, averaging 
across the sample of treated units to obtain a single treated unit.18,20
ƒĺƓՊ|Պ;m;u-Ѵb;7vm|_;|b11om|uoѴŐ"ől;|_o7
The GSC approach41 assumes that treatment assignment is inde-
pendent of potential outcomes conditional on the observed covari-
ates, and R orthogonal, unobserved latent factors (흀t=휆t1,… ,휆tR) and 
their factor loadings (흁i=휇i1,… ,휇iR)
41:
which implies that
This will hold true if the same IFE data generating process, such 
as equation 1 above, underlies outcomes for the treated and the 
control units. The key difficulty in estimating the unobserved treat-
ment-free potential outcome of the treated units in the post-treat-
ment periods is estimating 흀t for the post-treatment period and 흁i 
for each treated unit. The GSC approach tackles these difficulties 
as follows:]Ք
First, an IFE model, Y0
it
=Xit휷+흀t흁i+휀it, is estimated for the con-
trol units only, for the entire sample period, yielding estimates (휷̂ ,흀̂t) 
for the control units. Since 휏itDit is zero in equation 1 for the control 
units, (휷̂ ,흀̂t) are consistent estimates of (휷 ,흀t), which are assumed to 
be the same for the treated and control units. If we knew 흁i for the 
treated units, we could use our estimates from the control group 
(휷̂ ,흀̂t) to predict the post-treatment treatment-free potential out-
come for the treated unit using:
Since we do not know 흁i for each treated unit, the GSC method 
finds the value, 흁̂i, that minimizes the pretreatment discrepancy be-
tween the observed outcome and the predicted outcome for a given 
treated unit, based on [4].41 Using the estimates for 휷̂ and 흀̂t from the 
control units and the resulting prediction 흁̂i for the treated unit, we 
can estimate the treatment-free potential outcome for the treated 
units as:
The estimated treatment-free potential outcomes after the pro-
gram starts can be compared to the actual outcomes for the treated 
units to obtain an estimated treatment effect �̂it= (Y
�
it
−
̂Y0
it
) for each 
unit in each period. Since, unlike the IFE approach, estimates of 휷̂, 흀̂t 
and 흁̂i do not depend on post-treatment information for the treated 
units, �̂it is not biased by heterogeneous treatment effects.
As with the SC method, when the number of pretreatment pe-
riods is small, it becomes harder to distinguish between 흁i and 휀it
, which can lead to biased estimates of the treatment effect. This 
bias shrinks to zero as both the number of pretreatment periods and 
the size of the control group grow.41 Unlike the SC method, the GSC 
method conveniently allows for time-varying observed covariates. 
The GSC approach requires data be available for R + 1 pre-interven-
tion periods._Ք
ƓՊ |Պ$$$	"
$!Ŋ+""$!
!  $&!"
We replicated the DiD and SC estimations reported in a previously 
published study.2 The DiD estimation was undertaken at the hospital-
level and controlled for covariates (age, gender, source of admission), 
together with two-way fixed effects for time periods and hospitals. 
The SC method averaged the treated units to define a single treated 
unit, and a synthetic control was formed from the control units. In our 
implementation of the SC method, we included all of the pre-inter-
vention outcomes as separate variables in the X0 and X1 matrices. The 
variable weights were determined simultaneously with the synthetic 
control weights17 as implemented in the Stata package synth.
The IFE model was estimated using the iterative principal com-
ponent estimator.37 In our implementations of IFE and GSC, we in-
cluded the time-varying covariates in the IFE model, two-way fixed 
effects, and up to five interactive fixed effects with the number 
Y
0
it
⊥Dit|
(
Y
0
ih
) (
A2: Independence conditional on past outcomes
)
.
{
Y
1
it
,Y0
it
}
⊥Di|Xit,흀t,흁i
(A3)E
(
Y
1
it
,Y0
it
|Di=1,Xit,흀t,흁i
)
=E
(
Y
1
it
,Y0
it
|Di=0,Xit,흀t,흁i
)
(4)̂Y�
it
=Xit휷̂+ 흀̂t흁i
(5)̂Y0
it
=Xit휷̂+ 흀̂t흁̂i
ѵՊ|ՊՊՍ
Health Services Research
O'NEILL ET AL.
chosen by cross-validation, following Algorithm 1 in Xu.41 For infer-
ence, we used a parametric bootstrap with 500 replications.
For each method, we report p-values using the most common 
approach to inference for each approach, but recognizing that there 
are differences across methods that limit comparability of the re-
sultant p-values across methods.bՔ For the SC method, we use pla-
cebo tests for inference2,17; for the GSC method, we use a bootstrap 
approach41; and for the DiD and IFE methods, we report p-values 
based on cluster-robust standard errors.
ƔՊ |Պ"& $"$&	+
We compare the methods in a Monte Carlo Simulation study where 
the true ATT is known and contrast the approaches according to 
mean bias (%) and RMSE. Building from the case study, we create 
500 datasets of 111 units, of which 62 (49) were assigned to treat-
ment (control) as in the case studyfՔ and simulate data for up to 22 
periods, with four of these assigned to be post-treatment. The data 
generating process (DGP) includes one observed covariate (Xit), 
2-way additive fixed effects (μi1 and λ1t), and a further two interacted 
factors and an additive treatment effect:
We draw Xi, 휇i1, 휇i2, and 휇i3 from a standard multivariate normal 
distribution and 휆1t from a uniform(0,5) distribution.
hՔ To create a 
time-varying Xit, we then define Xit=0.5Xi+0.5∗N
(
0,1
)
. Here, 휀it is a 
standard normally distributed idiosyncratic error term. To introduce 
imbalance between the treated and control groups, the means of 휇i1, 
휇i2, and 휇i3 are set two standard deviations higher for the treated units 
than for the controls. In scenario A, we ensure the parallel trends as-
sumption holds by setting 휆2t=휆3t=0, so the DGP becomes a standard 
two-way fixed effects model. In scenario B, we allow for monotonically 
increasing nonparallel trends by setting 휆2t=0.2∗ t and 휆3t=0.1∗ t.
The performance of the SC method in scenario B may be negatively 
affected by our inclusion of time-varying covariates (Xit) since the SC 
weights are time-invariant, and by the imbalance in µ leading to treated 
units that lie outside of the convex hull of the controls. Scenario C rep-
resents a setting without these specific challenges. Here, we use Xi in 
place of Xit so that we have time-invariant covariates, and to ensure 
that the average treated unit lies in the convex hull of the controls, for 
25% of the control units we increase 휇i2 and 휇i3 by 4 standard devia-
tions so that these unit's outcomes are likely to lie above those of the 
average treated unit, while the remaining 75% of controls tend to lie 
below. In scenario D, we include an additional postintervention shock, 
Δ휀it=2, that only affects the treated group.
We consider scenarios (A1, B1, C1, and D1) where the treatment 
effect is homogenous (휏it=1), and otherwise identical scenarios (A2, 
B2, C2 & D2) with a heterogeneous treatment effect, in which we 
define 휏it=
(
1+
(
휇i1−2
))
.ѴՔ We then apply each method to estimate 
the average treatment effect for the treated group as a whole over 
the postintervention period. We consider the methods' performance 
across pretreatment periods of different lengths (6, 9, 12, and 18 pe-
riods). Finally, we assess the impact of imbalance in the numbers of 
treated (n = 10) vs control (n = 100) units (scenario E; Appendix S1).
ѵՊ |Պ!"&$"
ѵĺƐՊ|Պ-v;v|7u;vѴ|v
The estimated effects of the introduction of the BPT for hip frac-
tures according to method are reported in Table 1. For both end-
points, the IFE method reports that the magnitude of the effect of 
BPT is larger than for the other methods. However, since differences 
in unobserved covariates, such as hospital quality, are likely to mod-
ify the effects of the policy, this may reflect bias due to heterogene-
ous treatment effects.
The DiD, SC, and GSC methods provide similar point estimates. The 
p-values do differ somewhat across the approaches, but the interpre-
tation of these differences must recognize that the SC approach to in-
ference differs to the other methods. The GSC method reports that the 
introduction of BPT increases the proportion of patients who have sur-
gery within 48 hours, and suggests that the scheme leads to a reduc-
tion in mortality although this difference is not statistically significant.
ѵĺƑՊ|Պ"blѴ-|bomu;vѴ|v
Figure 3 presents boxplots of the simulation estimates for each sce-
nario by method, while Table 2 reports the corresponding mean bias 
Yit=Xit훽+휇i1+휆1t+휆2t휇i2+휆3t휇i3+Dit휏it+휀it
$     Ɛ Պ Best Practices Tariffs case study results: ATT on process and outcome measures according to method
 	b==;u;m1;ŊbmŊ7b==;u;m1;v "m|_;|b11om|uoѴv
m|;u-1|b;=b;7
;==;1|v
;m;u-Ѵb;7
vm|_;|b11om|uoѴv
Surgery within 48 h 0.0403 0.0482 0.0647 0.0590
(P = .196) (P = .250) (P = .004) (P = .004)
Dead within 30 d ƴƏĺƏƏѶƏ ƴƏĺƏƏƔƐ ƴƏĺƏƐƑƒ ƴƏĺƏƏѵƑ
(P = .037) (P = .560) (P < .001) (P = .308)
Note: For difference in differences, O'Neill et al2 report p-values based on cluster robust standard errors. For the synthetic control method, p-values 
are based on placebo tests as described in O'Neill et al2; for interactive fixed effects, we report p-values based on cluster robust standard errors and 
the generalized synthetic control approach uses a bootstrap approach as described in Xu.41
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(%) and root mean squared error (RMSE). We begin by considering the 
scenarios where effects are homogenous (scenario A1, B1, C1, and D1, 
panel (a) of Figure 3). As expected if the parallel trends assumption 
holds, DiD performs best (scenario A1), although IFE and GSC perform 
almost as well (Table 2, Figure 3(I)). By contrast, SC performs poorly, 
providing biased estimates attributable to the average treated unit 
tending to lie outside the convex hull of controls. Where the parallel 
trends assumption fails (scenario B1), DiD provides biased estimates, 
whereas IFE and GSC report minimal bias (Table 2, Figure 3(ii)). The SC 
method again provides biased estimates. In scenario C1, the perfor-
mance of the SC method improves markedly (Table 2, Figure 3(iii)) since 
here the treated units tend to lie inside the convex hull of the controls. 
When a shock has a differential effect for the treated vs control group 
in the postintervention period (scenario D1), all methods provide bi-
ased estimates (Table 2, Figure 3(iv)).
In those scenarios with heterogeneous treatment effects (scenar-
ios A2, B2, and C2, panel (b) of Figure 3), the GSC method continues to 
perform well, providing estimates with low bias and low RMSE (Table 2, 
Figure 3(i), (ii) (iii), (iv)). DiD, IFE, and SC all report biased estimates. For 
DiD, the bias is due to the failure of the parallel trends assumption. 
For the IFE model, the heterogeneous treatment effect biases the esti-
mated values for 흀t흁i, which in turn biases the treatment-free potential 
outcome and ultimately the ATT. For the SC method, the bias is attrib-
utable to poor overlap and is mitigated when the treated units lie in the 
convex hull of the controls (scenario C2). In scenario D2, all methods 
again report bias due to the postintervention shock.
ƕՊ |Պ	"&""
This paper critically assesses two causal inference approaches, 
IFE and GSC methods, new to health policy evaluation, and con-
trasts them with DiD estimation and the SC method. The paper 
extends previous papers in the health policy and political science 
literatures4-15,41,74 in contrasting IFE and GSC, but also approaches 
often considered in the HSR literature (DID and SC). Rather than 
focus solely on simple scenarios,41 the paper considers a range 
of settings relevant to the HSR context, including homogeneous 
and heterogeneous treatment effects, parallel tends and nonpar-
allel tends, highly imbalanced numbers of treatment and control 
units, serial correlation, and idiosyncratic shocks. While our paper 
underscores the main finding from Xu's early simulation study,41 
that GSC performs better than IFE when there is treatment ef-
fect heterogeneity, it offers a wider set of insights into the relative 
performance of GSC vs alternative methods in settings of direct 
relevance to the HSR context.
Our re-evaluation of the BPT scheme exemplifies many criti-
cal issues faced in health policy evaluations. Here, there are mul-
tiple outcomes with the parallel trends assumption plausible for 
some but not others; the effects of the policy are anticipated to 
differ across hospitals; and data are only available for relatively 
few periods pre-intervention. An attractive feature of the IFE and 
GSC methods is that they allow the analyst to adopt a consistent 
analytical approach across all outcomes, as their factor structure 
allows greater flexibility in controlling for unobserved confound-
ers. However, the IFE estimator assumes homogenous treatment 
effects, which is unlikely in this study. Here, the GSC method is 
preferred in light of its robustness to the assumption of parallel/
nonparallel trends and homogeneous/heterogeneous effects. 
It reported that BPT led to a largelՔ and statistically significant 
increase in the proportion of patients who had surgery within 
48 hours of admission, together with a small, but not statistically 
significant, reduction in 30-day mortality.
The simulation study found that the GSC approach performed 
better than the alternatives considered across a range of challenging 
settings typically faced in health economic and policy evaluations 
that use routine data, namely nonparallel trends, heterogeneous 
treatment effects, and few (6) pre-intervention periods. However, 
when deciding which methods to apply to a particular setting, it is 
important to consider the underlying theory and requirements of 
the method. In particular, GSC and IFE approaches both require re-
peated observations of the same units over time (ie, panel data) and 
also require data for multiple pre-intervention periods (one more 
than the specified number of interactive fixed effects to include).
Generalized synthetic control reports relatively precise esti-
mates across all these challenging settings. We find the method 
performs well even if there is limited support for particular under-
lying causal assumptions (eg, parallel trends). In light of this, for the 
case study, which has some of these features, we emphasize the 
policy conclusions from the GSC approach, which is that the BPT 
intervention increased the probability of surgery within 48 hours, 
but does not lead to a change in 30-day mortality. We also con-
tribute to the growing literature that critically evaluates the SC 
method.2,26 We extend O'Neill et al2 in recognizing that the SC 
method can perform badly if there is poor overlap in the pretreat-
ment outcomes between the treated and control units, specifically 
when treated units lie outside the convex hull of the controls17,41mՔ. 
Conversely, we highlight that the SC method can perform well pro-
vided the treated observations do lie within the convex hull of the 
controls. Hence, future studies should consider carefully whether 
their evaluations have these features before opting for SC as an 
alternative for DiD estimation.
This paper has the following limitations. First, each of the meth-
ods considered assumes that idiosyncratic shocks postintervention 
have the same expected effect on outcomes for the treated and 
control groups. Similarly, while any of these approaches can incor-
porate individual-level baseline information, for example, on patient 
case mix, by “risk adjusting” outcomes, unobserved compositional 
changes in the postintervention period may be wrongly attributed 
to the effect of the intervention. Second, to aid transparency, the 
Monte Carlo simulation study had a relatively simple DGP and as-
sumed the IFE models including the one underlying the GSC method 
were correctly specified. A natural next step would be to contrast 
the IFE and GSC approaches to other relatively untested methods 
from the general causal inference literature.29,31-33 Third, in empir-
ical studies the methods would ideally be contrasted by applying 
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the same randomization inference procedure. The Conley-Taber 
randomization inference procedure has been recommended for this 
purpose, but requires the same number of observations across the 
treated and control groups.63
The findings from this paper and ongoing methods development 
more widely highlight two complementary areas for further research. 
First, a number of extensions to DiD have been proposed to increase 
the validity of DiD-type estimators including: allowing for unit-specific 
trends,64,65 combining matching with DiD,66 and combining instrumen-
tal variables (IV) approaches with DiD.67 While combining IV with DiD 
would allow for unobserved confounding, the population this estimate 
relates to (compliers) may not be of policy relevance.
   & !   ƒ Պ Boxplot of mean % bias in 
treatment effect estimates from Monte 
Carlo simulation. (i) Scenarios A: parallel 
trends, (ii) Scenario B: non-parallel trends, 
(iii) Scenario C: non-parallel trends, time-
invariant covariates and treated units 
lying inside the convex hull of controls, 
(iv) Scenario D: non-parallel trends with 
group specific shock post-intervention. 
Note: 500 simulations. Tpretreatment is 
the number of pre-treatment periods. 
Abbreviations: DiD, difference in 
differences; GSC, generalised synthetic 
control; IFE, interactive fixed effecs; SC= 
Synthetic control method [Color figure 
can be viewed at wileyonlinelibrary.com]
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Second, the limitations of the originally proposed SC method16,17 
have led to recent modifications. The augmented SC approach71 ad-
dresses the bias due to non-exact balance on pretreatment outcomes. 
The imperfect SC35 reduces the sensitivity of estimates to idiosyn-
cratic errors by applying SC to predicted rather than actual outcomes. 
A number of approaches relax the overlap requirement by allowing for 
negative weights.29,35,71 Extensions of the SC method using machine 
learning methods such as ridge regression71 and the matrix comple-
tion approach31 appear promising. Inference for SC type methods is 
an area of active research, with several authors proposing extensions 
to the originally proposed placebo tests.29,32,70 Future work is re-
quired that considers the relative performance of these methods and 
reports the coverage of alternative inferential procedures.
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Parallel trends Holds Holds Fails Fails Fails Fails Fails Fails
Homogenous treatment effects Yes No Yes No Yes No Yes No
Time-invariant covariates and 
treated units in convex hull
No No No No Yes Yes No No
Group-specific shock 
postintervention
No No No No No No Yes Yes
18 pre-treatment periods
Difference-in-differences 0.01 0.01 43.74 43.74 10.78 10.78 74.25 74.25
Synthetic controls 0.09 0.09 4.46 4.46 0.06 0.06 14.88 14.88
Interactive fixed effects 0.01 0.36 0.06 1.88 0.02 0.11 4.37 6.43
Generalized synthetic controls 0.01 0.01 0.07 0.07 0.02 0.02 4.28 4.28
12 pre-treatment periods
Difference-in-differences 0.01 0.01 23.19 23.19 5.65 5.65 46.38 46.38
Synthetic controls 0.11 0.11 3.97 3.97 0.07 0.07 13.47 13.47
Interactive fixed effects 0.02 0.32 0.14 0.71 0.04 0.14 4.04 1.70
Generalized synthetic controls 0.02 0.02 0.11 0.11 0.03 0.03 4.30 4.30
9 pre-treatment periods
Difference-in-differences 0.01 0.01 15.34 15.34 3.78 3.78 34.93 34.93
Synthetic controls 0.13 0.13 3.80 3.80 0.10 0.10 12.98 12.98
Interactive fixed effects 0.02 0.34 0.17 0.98 0.05 0.17 4.19 1.52
Generalized synthetic controls 0.02 0.02 0.18 0.18 0.05 0.05 4.58 4.58
6 pre-treatment periods
Difference-in-differences 0.02 0.02 9.05 9.05 2.24 2.24 24.98 24.98
Synthetic controls 0.16 0.16 3.66 3.66 0.13 0.13 12.97 12.97
Interactive fixed effects 0.03 0.33 0.19 1.33 0.09 0.19 4.27 1.39
Generalized synthetic controls 0.03 0.03 0.34 0.34 0.10 0.10 5.00 5.00
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a A recent working paper by Schmidt et al69 uses the GSC method to as-
sess whether insurance coverage of medical treatments with high out-of-
pocket costs affects patients' utilization. 
b See McDonald et al42 and Kristensen et al 68 for further details. 
c Here, participation status is defined according to whether the hospi-
tal trust had reported receiving any BPT payments for hip fractures in 
2010/11.42 
d The test for parallel trends is described in Appendix C of O'Neill et al2 
e The general framework in equation 1 also nests unit-specific linear 
trends,64,65 which would be obtained if we specify 흁i =
[
1,휇i ,휇i
]
 and 흀t =
[
휆t ,t,1
]
. 
f Under staggered adoption, and heterogeneous effects, extra care must 
be taken to identify the effect being estimated.72,73 
g Gobillon and Magnac30 suggest a similar approach that uses an expecta-
tion maximization approach. 
h Sample code to estimate all of the methods is available from the authors 
on request. 
i For instance, placebo tests capture whether the estimated effect for the 
treated group (or unit) is large relative to the effect that would have been 
estimated for a treatment group (or unit) chosen at random.17 This con-
trasts with the more common random sampling perspective underlying 
standard errors for regression models.28 
j Results were similar when 10 treated units and 100 control units were 
used instead. 
k We allow for correlation between Xit, 휇i1, 휇i2, and 휇i3 with the correlation 
matrix, C = (1, 0.5, 0.5, 0.3 \ 0.5, 1, 0.5, 0.3 \ 0.5, 0.5, 1, 0.5 \ 0.3, 0.3, 0.5, 
1). 
l Note that since E(μi1 |Dit = 1)=2 here, the true ATT is 1 in all scenarios. 
m The average rate of surgery within 48 hours was 58.3%. 
n Where the treated unit's outcomes are very different to those of the 
controls, the most similar control will receive a weight of 1 and be used 
as the counterfactual for the treated unit, even though it may be very 
dissimilar. 
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